Glovista Investments LLC Merck & Co., Inc. Transaction History

Glovista Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$83.49 - $94.64 $5,343 - $6,056	-64 Reduced 0.31%	20,832 $1.9 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $1.54 Million - $1.72 Million	20,896 New	20,896 $1.72 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $554,736 - $653,422	-8,056 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $578,179 - $641,660	8,056 New	8,056 $659,000
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $178,022 - $207,972	-2,549 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $219,177 - $249,984	-3,150 Reduced 55.27%	2,549 $212,000
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $32,619 - $37,855	-500 Reduced 8.07%	5,699 $435,000
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $10,192 - $11,846	-200 Reduced 3.13%	6,199 $338,000
Q4 2017 Feb 15, 2018	SELL	$51.62 - $61.64 $10,324 - $12,328	-200 Reduced 3.03%	6,399 $360,000
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $387,163 - $416,594	6,599	6,599 $423,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Glovista Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Glovista Investments LLC with notifications on news.